Literature DB >> 6290929

Transplantable canine glioma model for use in experimental neuro-oncology.

M Salcman, E W Scott, R S Schepp, H C Knipp, R D Broadwell.   

Abstract

The need for a large animal tumor model in experimental neuro-oncology led us to re-evaluate and to modify the transplantable canine glioma of Wodinsky and Walker. Successive passages of the original tumor brei were made in purebred beagles, from beagle to mongrel, and between various mongrel strains until an intracerebral injection of 0.1 cc on Days 1 to 3 of life produced a 93% incidence of tumor take in all breeds. The mean survival was 13.5 +/- 1.9 days after injection (range, 10 to 19 days) in 10 litters. The tumor was invariably fatal and possessed many of the histological characteristics of human glioblastoma (i.e., capillary proliferation, pseudopallisading, frequent mitotic figures, and multinucleated giant cells). The animals were large enough to be scanned on the Pfizer 450 scanner, and the tumors were visualized in vivo as typical "ring" lesions after the injection of contrast agent. Intravital staining with Evans blue outlined the areas of contrast enhancement observed in the same tumors by computed tomography. The apparent defect in the blood-brain barrier could be explained in part by the absence of endothelial tight junctions on electron microscopy. Stability in the histology and activity of the tumor could be demonstrated after more than 14 months of storage at -70 degrees C. The transplantable canine glioma model has many advantages including low cost, reproducible morphology, a short survival time, and relative safety for the investigator. The large size of the animal preparation allows the use of complex surgical instrumentation and radiographic study, as well as repeated sampling of cerebrospinal and other fluids.

Entities:  

Mesh:

Year:  1982        PMID: 6290929     DOI: 10.1227/00006123-198209000-00007

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  8 in total

1.  Allogeneic astrocytoma in immune competent dogs.

Authors:  M E Berens; A Giese; J R Shapiro; S W Coons
Journal:  Neoplasia       Date:  1999-06       Impact factor: 5.715

2.  The effect of regadenoson-induced transient disruption of the blood-brain barrier on temozolomide delivery to normal rat brain.

Authors:  Sadhana Jackson; Nicole M Anders; Antonella Mangraviti; Teresia M Wanjiku; Eric W Sankey; Ann Liu; Henry Brem; Betty Tyler; Michelle A Rudek; Stuart A Grossman
Journal:  J Neurooncol       Date:  2015-12-01       Impact factor: 4.130

3.  A novel brainstem tumor model: functional and histopathological characterization.

Authors:  George I Jallo; Andrey Volkov; Cyrus Wong; Benjamin S Carson; Margaret B Penno
Journal:  Childs Nerv Syst       Date:  2006-10-05       Impact factor: 1.475

4.  Retroviral delivery of platelet-derived growth factor to spinal cord progenitor cells drives the formation of intramedullary gliomas.

Authors:  Jason A Ellis; Michael Castelli; Jeffrey N Bruce; Peter Canoll; Alfred T Ogden
Journal:  Neurosurgery       Date:  2012-01       Impact factor: 4.654

5.  Morphometrical characterization of two glioma models in the brain of immunocompetent and immunodeficient rats.

Authors:  M Saini; M Bellinzona; F Meyer; G Cali; M Samii
Journal:  J Neurooncol       Date:  1999-03       Impact factor: 4.130

6.  Immunohistochemical study of glial fibrillary acidic protein in avian sarcoma virus-induced gliomas in dogs.

Authors:  R H Britt; B E Lyons; L F Eng; S H Bigner; D D Bigner
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

7.  Tumorigenic, invasive, karyotypic, and immunocytochemical characteristics of clonal cell lines derived from a spontaneous canine anaplastic astrocytoma.

Authors:  M E Berens; G Bjotvedt; D C Levesque; M D Rief; J R Shapiro; S W Coons
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-04       Impact factor: 2.416

Review 8.  Blood flow and blood-to-tissue transport in 9L gliosarcomas: the role of the brain tumor model in drug delivery research.

Authors:  R D Fross; P C Warnke; D R Groothuis
Journal:  J Neurooncol       Date:  1991-12       Impact factor: 4.130

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.